CLDN4 and neoplasm: Despite exhibiting a low binding affinity (1.93 ± 0.59 μM), this radiotracer revealed claudin-4-mediated tumour uptake in a variety of human cancer xenograft and genetically engineered models which were all found to have upregulated claudin-4 expression.